ASIATIC LABORATORIES LIMITED

Business Segments Asiatic Laboratories Limited

Stocks

ASIATICLAB

BD0498ALL007

End-of-day quote Dhaka S.E. 2026-09-15			5-day change	1st Jan Change
108.30 ^BDT	+2.95%		+2.85%	+128.00%

06-14	Asiatic Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2026	CI
02-21	32,839,510 Ordinary Shares of Asiatic Laboratories Limited are subject to a Lock-Up Agreement Ending on 22-FEB-2026.	CI

Sales 2025 by Business Segment

© MarketScreener.com See more

Sales 2025 by Geography

© MarketScreener.com See more

Historical Breakdown of Revenue by Business Segments

Net Income: Breakdown by Business Segment

Geographical Revenue Distribution History

Breakdown by Business Segment (BDT)

Fiscal Period: June	2020	2021	2022	2023	2024	2025
Pharmaceutical Products
Pharmaceuticals		1.45B	1.47B	1.29B	1.39B	1.77B
Total Assets		5.86B	6.26B	6.92B	7.42B	8.87B
Interest Expense		-43.92M	-41.02M	-54.13M	-49.98M	-199M
Income Tax Expense		50.95M	107M	88.22M	30.51M	75.34M
CAPEX		-375M	-	-359M	-787M	-1.3B
EBT		371M	376M	294M	309M	331M
Gross Profit		623M	637M	547M	586M	767M
D&A		105M	-	137M	151M	165M
Operating Income		434M	434M	350M	356M	545M
Net Income		321M	269M	206M	278M	255M

Geographical breakdown of sales (BDT)

Fiscal Period: June	2020	2021	2022	2023	2024	2025
Bangladesh		967M	1.33B	1.29B	1.39B	1.77B
Export		484M	144M	-	-	-
		-	-	1.29B	1.39B	1.77B

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!

SEIZE THE OFFER!